Skip to main content
Caplight Logo









Spot Biosystems

Spot Biosystems

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://www.spotbiosystems.com/

Last Round

VC Round

Jun 17, 2026

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Spot Biosystems is a biotechnology company that develops non-viral gene therapies using a proprietary extracellular vesicle delivery platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyextracellular vesiclesEVnon-viral deliverygenetic medicineDuchenne muscular dystrophyDMDmRNA deliverybiotechnologyrare disease therapydrug delivery platformgenetic payloadbiotech startupnext-gen gene therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spot Biosystems Comparables

Compare Spot Biosystems with similar companies based on industry and business-model similarity.

Spot Biosystems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Myosana Therapeutics
89%
Carmine Therapeutics
85%
Orphina Biotechnology
82%

Spot Biosystems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 17, 2026

Spot Biosystems Investors

Notable investors and investment history

Spot Biosystems investors
InvestorRounds
IDG CapitalVC Round
Tiger Jade CapitalVC Round
Advantech CapitalVC Round
LDV PartnersVC Round
Shanda GroupVC Round
Saltagen VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 291% MoM, from 390 to 1.5K.

  • Jun 17, 2026

    $40M raised from Shanda Group and Tiger Jade Capital.

Recent news

Latest coverage and updates

  • receives_financingJun 22, 2026

    Spot Biosystems received financing of $40M in venture financing on Jun 18th '26.

  • is_developingJun 18, 2026

    Spot Biosystems is developing non-viral gene therapy platform aimed at Duchenne muscular dystrophy on Jun 18th '26.

Spot Biosystems Filings

Explore SEC and related filing metadata, where available.

Spot Biosystems filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Spot Biosystems's valuation, stock price, and market status.

Is Spot Biosystems a public or private company?

Spot Biosystems is a private company.

What is the current stock price of Spot Biosystems?

Spot Biosystems is a private company with no public stock price. No recent secondary market data is available.

How much is Spot Biosystems worth (valuation)?

Valuation information for Spot Biosystems is not publicly available.

Can I buy Spot Biosystems stock?

Spot Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Spot Biosystems's last funding round?

Funding round information for Spot Biosystems is not publicly available.

Who are the main investors in Spot Biosystems?

Investor information for Spot Biosystems is not publicly disclosed.

Will Spot Biosystems IPO soon?

No public IPO plans have been announced for Spot Biosystems.

How can I track Spot Biosystems secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spot Biosystems's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range4
Year Founded2018
Last FundingJun 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?